Antioxidant and bioenergetic coupling between neurons and astrocytes

Biochemical Journal

Volumn 443, Issue 1, 2012, Pages 3-12

  Fernandez Fernandez, Seila ^a   Almeida, Angeles ^a,b   Bolaños, Juan P ^a  

^a UNIVERSITY OF SALAMANCA   (Spain)

^b HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

Author keywords

6 phosphofructo 2 kinase fructose 2,6 bisphosphatase isoform 3 (PFKFB3); Anaphase promoting complex (APC); Cdh1; Glycolysis; Pentose phosphate pathway

Indexed keywords

6 PHOSPHOGLUCONOLACTONE; ANAPHASE PROMOTING COMPLEX; CALCIUM; CYCLIC GMP; GLUCOSE; GLUTATHIONE; LACTONE DERIVATIVE; PENTOSE PHOSPHATE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; SHORT HAIRPIN RNA; SUPEROXIDE; SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANAPHASE; ANTIOXIDANT ACTIVITY; APOPTOSIS; ASTROCYTE; BIOENERGY; CELL SURVIVAL; DEGENERATIVE DISEASE; GLUCOSE OXIDATION; GLYCOLYSIS; HUMAN; IN VIVO STUDY; NERVE CELL; NERVE DEGENERATION; NEUROPROTECTION; NITROSATIVE STRESS; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; STROKE; SURVIVAL;

ANIMALS; ANTIOXIDANTS; ASTROCYTES; CARBOHYDRATE METABOLISM; ENERGY METABOLISM; GLUTATHIONE; HUMANS; NEURONS; OXIDATION-REDUCTION; OXIDATIVE STRESS;

EID: 84858306047     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20111943     Document Type: Review

References (160)

1. Jellinger, K. A. (2010) Basic mechanisms of neurodegeneration: a critical update. J. Cell. Mol. Med. 14, 457-487
2. Agostinho, P., Cunha, R. A. and Oliveira, C. (2010) Neuroinflammation, oxidative stress and the pathogenesis of Alzheimer's disease. Curr. Pharm. Des. 16, 2766-2778
3. Bolaños, J. P., Almeida, A., Stewart, V., Peuchen, S., Land, J. M., Clark, J. B. and Heales, S. J. R. (1997) Nitric oxide-mediated mitochondrial damage in the brain: mechanisms and implications for neurodegenerative diseases. J. Neurochem. 68, 2227-2240 (Pubitemid 27218141)
4. Bolaños, J. P., Moro, M. A., Lizasoain, I. and Almeida, A. (2009) Mitochondria and reactive oxygen and nitrogen species in neurological disorders and stroke: therapeutic implications. Adv. Drug Delivery Rev. 61, 1299-1315
5. Kamat, C. D., Gadal, S., Mhatre, M., Williamson, K. S., Pye, Q. N. and Hensley, K. (2008) Antioxidants in central nervous system diseases: preclinical promise and translational challenges. J. Alzheimer's Dis. 15, 473-493
6. Murphy, M. P. (2009) How mitochondria produce reactive oxygen species. Biochem. J. 417, 1-13
7. Kinuta, Y., Kimura, M., Itokawa, Y., Ishikawa, M. and Kikuchi, H. (1989) Changes in xanthine oxidase in ischemic rat brain. J. Neurosurg. 71, 417-420 (Pubitemid 19225555)
8. Lipton, P. (1999) Ischemic cell death in brain neurons. Physiol. Rev. 79, 1431-1568
9. Halliwell, B. (2006) Oxidative stress and neurodegeneration: where are we now? J. Neurochem. 97, 1634-1658
10. Garthwaite, J., Charles, S. L. and Chess-Williams, R. (1988) Endothelium-derived relaxing factor release on activation of NMDA receptors suggests a role as intercellular messenger in the brain. Nature 336, 385-387
11. Knowles, R. G. and Moncada, S. (1994) Nitric oxide synthases in mammals. Biochem. J. 298, 249-258 (Pubitemid 24072462)
12. Knowles, R. G., Palacios, M., Palmer, R. M. J. and Moncada, S. (1989) Formation of nitric oxide from L-arginine in the central nervous system: a transduction mechanism for stimulation of the soluble guanylate cyclase. Proc. Natl. Acad. Sci. U.S.A. 86, 5159-5162 (Pubitemid 19182253)
13. Bredt, D. S. and Snyder, S. H. (1989) Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum. Proc. Natl. Acad. Sci. U.S.A. 86, 9030-9033 (Pubitemid 20010361)
14. Schulz, J. B., Matthews, R. T. and Beal, M. F. (1995) Role of nitric oxide in neurodegenerative diseases. Curr. Opin. Neurol. 8, 480-486 (Pubitemid 26039809)
15. Murphy, S., Simmons, M. L., Agulló, L., García, A., Feinstein, D. L., Galea, E., Reis, D. J., Minc-Golomb, D. and Schwartz, J. P. (1993) Synthesis of nitric oxide in CNS glial cells. Trends Neurosci. 16, 323-328 (Pubitemid 23190649)
16. Bolaños, J. P. and Almeida, A. (1999) Roles of nitric oxide in brain hypoxia-ischemia. Biochim. Biophys. Acta 1411, 415-436 (Pubitemid 29221965)
17. Rees, D. D., Palmer, R. J. M. and Moncada, S. (1989) Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc. Natl. Acad. Sci. U.S.A. 86, 3375-3378 (Pubitemid 19129614)
18. Iadecola, C. (1997) Bright and dark sides of nitric oxide in ischemic brain injury. Trends Neurosci. 20, 132-139
19. Attwell, D., Buchan, A. M., Charpak, S., Lauritzen, M., Macvicar, B. A. and Newman, E. A. (2010) Glial and neuronal control of brain blood flow. Nature 468, 232-243
20. Chinta, S. J. and Andersen, J. K. (2011) Nitrosylation and nitration of mitochondrial complex I in Parkinson's disease. Free Radical Res. 45, 53-58
21. Blough, N. V. and Zafiriou, O. C. (1985) Reactions of superoxide with nitric oxide to form peroxonitrite in alkaline aqueous solution. Inorg. Chem. 24, 3502-3504
22. Beckman, J. S., Beckman, T. W., Chen, J., Marshall, P. A. and Freeman, B. A. (1990) Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. U.S.A. 87, 1620-1624
23. Ischiropoulos, H., Zhu, L. C., Chen, J., Tsai, M., Martin, J. C., Smith, C. D. and Beckman, J. S. (1992) Peroxynitrite-mediated tyrosine nitration catalyzed by superoxide dismutase. Arch. Biochem. Biophys. 298, 431-437
24. Bolaños, J. P., García-Nogales, P. and Almeida, A. (2004) Provoking neuroprotection by peroxynitrite. Curr. Pharm. Des. 10, 867-877 (Pubitemid 38380065)
25. Beckman, J. S., Carson, M., Smith, C. D. and Koppenol, W. H. (1993) ALS, SOD and peroxynitrite. Nature 364, 584
26. Diaz-Amarilla, P., Olivera-Bravo, S., Trias, E., Cragnolini, A., Martinez-Palma, L., Cassina, P., Beckman, J. and Barbeito, L. (2011) Phenotypically aberrant astrocytes that promote motoneuron damage in a model of inherited amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. U.S.A. 108, 18126-18131
27. Oury, T. D., Ho, Y. S., Piantadosi, C. A. and Crapo, J. D. (1992) Extracellular superoxide dismutase, nitric oxide, and central nervous system O2 toxicity. Proc. Natl. Acad. Sci. U.S.A. 89, 9715-9719
28. Brown, G. C. and Neher, J. J. (2010) Inflammatory neurodegeneration and mechanisms of microglial killing of neurons. Mol. Neurobiol. 41, 242-247
29. Schweizer, M. and Richter, C. (1994) Nitric oxide potently and reversibly deenergizes mitochondria at low oxygen tension. Biochem. Biophys. Res. Commun. 204, 169-175 (Pubitemid 24335277)
30. Brown, G. C. and Cooper, C. E. (1994) Nanomolar concentrations of nitric oxide reversibly inhibit synaptosomal respiration by competing with oxygen at cytochrome oxidase. FEBS Lett. 356, 295-298 (Pubitemid 24376992)
31. Bolaños, J. P., Peuchen, S., Heales, S. J. R., Land, J. M. and Clark, J. B. (1994) Nitric oxide-mediated inhibition of the mitochondrial respiratory chain in cultured astrocytes. J. Neurochem. 63, 910-916 (Pubitemid 24266603)
32. Sharpe, M. A. and Cooper, C. E. (1998) Interaction of peroxynitrite with mitochondrial cytochrome oxidase. J. Biol. Chem. 273, 30961-30972
33. Bosetti, F., Brizzi, F., Barogi, S., Mancuso, M., Siciliano, G., Tendi, E. A., Murri, L., Rapoport, S. I. and Solaini, G. (2002) Cytochrome c oxidase and mitochondrial F1F0-ATPase (ATP synthase) activities in platelets and brain from patients with Alzheimer's disease. Neurobiol. Aging 23, 371-376 (Pubitemid 34312019)
34. Cho, D. H., Nakamura, T., Fang, J., Cieplak, P., Godzik, A., Gu, Z. and Lipton, S. A. (2009) S-nitrosylation of Drp1 mediates β-amyloid-related mitochondrial fission and neuronal injury. Science 324, 102-105
35. Choi, D. W. and Rothman, S. M. (1990) The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death. Annu. Rev. Neurosci. 13, 171-182 (Pubitemid 20100647)
36. Beal, M. F. (1992) Mechanisms of excitotoxicity in neurologic diseases. FASEB J. 6, 3338-3344
37. Castillo, J., Davalos, A., Naveiro, J. and Noya, M. (1996) Neuroexcitatory amino acids and their relation to infarct size and neurological deficit in ischemic stroke. Stroke 27, 1060-1065 (Pubitemid 26177607)
38. Almeida, A. and Bolaños, J. P. (2001) A transient inhibition of mitochondrial ATP synthesis by nitric oxide synthase activation triggered apoptosis in primary cortical neurons. J. Neurochem. 77, 676-690 (Pubitemid 32298762)
39. Moncada, S. and Bolanos, J. P. (2006) Nitric oxide, cell bioenergetics and neurodegeneration. J. Neurochem. 97, 1676-1689 (Pubitemid 43873660)
40. Bolaños, J. P., Almeida, A. and Moncada, S. (2010) Glycolysis: a bioenergetic or a survival pathway? Trends Biochem. Sci. 35, 145-149
41. Zhang, J., Dawson, V. L., Dawson, T. M. and Snyder, S. H. (1994) Nitric oxide activation of poly(ADP-ribose) synthetase in neurotoxicity. Science 263, 687-689 (Pubitemid 24076297)
42. Radi, R., Beckman, J. S., Bush, K. M. and Freeman, B. A. (1991) Peroxynitrite-induced membrane lipid peroxydation: the cytotoxic potential of superoxide and nitric oxide. Arch. Biochem. Biophys. 288, 481-487
43. Radi, R., Beckman, J. S., Bush, K. M. and Freeman, B. A. (1991) Peroxynitrite oxidation of sulfhydryls. The cytotoxic potential of superoxide and nitric oxide. J. Biol. Chem. 266, 4244-4250 (Pubitemid 21909347)
44. Raps, S. P., Lai, J. C. K., Hertz, L. and Cooper, A. J. L. (1989) Glutathione is present in high concentration in cultured astrocytes but not in cultured neurones. Brain Res. 493, 398-401 (Pubitemid 19183160)
45. Sagara, J., Miura, K. and Bannai, S. (1993) Maintenance of neuronal glutathione by glial cells. J. Neurochem. 61, 1672-1676 (Pubitemid 23317188)
46. Makar, T. K., Nedergaard, M., Preuss, A., Gelbard, A. S., Perumal, A. S. and Cooper, A. J. L. (1994) Vitamin E, ascorbate, glutathione, glutathione disulfide, and enzymes of glutathione metabolism in cultures of chick astrocytes and neurones: evidence that astrocytes play an important role in antioxidative processes in the brain. J. Neurochem. 62, 45-53
47. Bolaños, J. P., Heales, S. J. R., Land, J. M. and Clark, J. B. (1995) Effect of peroxynitrite on the mitochondrial respiratory chain: differential susceptibility of neurones and astrocytes in primary cultures. J. Neurochem. 64, 1965-1972
48. Dringen, R. (2000) Metabolism and functions of glutathione in brain. Progr. Neurobiol. 62, 649-671
49. Dringen, R., Kussmaul, L., Gutterer, J. M., Hirrlinger, J. and Hamprecht, B. (1999) The glutathione system of peroxide detoxification is less efficient in neurons than in astrocytes. J. Neurochem. 72, 2523-2530 (Pubitemid 29242204)
50. De Vos, K. J., Chapman, A. L., Tennant, M. E., Manser, C., Tudor, E. L., Lau, K. F., Brownlees, J., Ackerley, S., Shaw, P. J., McLoughlin, D. M. et al. (2007) Familial amyotrophic lateral sclerosis-linked SOD1 mutants perturb fast axonal transport to reduce axonal mitochondria content. Hum. Mol. Genet. 16, 2720-2728 (Pubitemid 350018514)
51. Bolaños, J. P., Heales, S. J. R., Peuchen, S., Barker, J. E., Land, J. M. and Clark, J. B. (1996) Nitric oxide-mediated mitochondrial damage: a potential neuroprotective role for glutathione. Free Radical Biol. Med. 21, 995-1001 (Pubitemid 26365953)
52. Heales, S. J. R. and Bolaños, J. P. (2002) Impairment of brain mitochondrial function by reactive nitrogen species: the role of glutathione in dictating susceptibility. Neurochem. Int. 40, 469-474 (Pubitemid 34159147)
53. Flohe, L., Toppo, S., Cozza, G. and Ursini, F. (2011) A comparison of thiol peroxidase mechanisms. Antioxid. Redox Signaling 15, 763-780
54. Patenaude, A., Murthy, M. R. and Mirault, M. E. (2005) Emerging roles of thioredoxin cycle enzymes in the central nervous system. Cell. Mol. Life Sci. 62, 1063-1080 (Pubitemid 40868526)
55. Papadia, S., Soriano, F. X., Leveille, F., Martel, M. A., Dakin, K. A., Hansen, H. H., Kaindl, A., Sifringer, M., Fowler, J., Stefovska, V. et al. (2008) Synaptic NMDA receptor activity boosts intrinsic antioxidant defenses. Nat. Neurosci. 11, 476-487 (Pubitemid 351441886)
56. Dringen, R., Pawlowski, P. G. and Hirrlinger, J. (2005) Peroxide detoxification by brain cells. J. Neurosci. Res. 79, 157-165 (Pubitemid 40116430)
57. Ho, Y. S., Xiong, Y., Ma, W., Spector, A. and Ho, D. S. (2004) Mice lacking catalase develop normally but show differential sensitivity to oxidant tissue injury. J. Biol. Chem. 279, 32804-32812 (Pubitemid 39014740)
58. Ho, Y. S., Magnenat, J. L., Bronson, R. T., Cao, J., Gargano, M., Sugawara, M. and Funk, C. D. (1997) Mice deficient in cellular glutathione peroxidase develop normally and show no increased sensitivity to hyperoxia. J. Biol. Chem. 272, 16644-16651 (Pubitemid 27276497)
59. Hayes, J. D., Chanas, S. A., Henderson, C. J., McMahon, M., Sun, C., Moffat, G. J., Wolf, C. R. and Yamamoto, M. (2000) The Nrf2 transcription factor contributes both to the basal expression of glutathione S-transferases in mouse liver and to their induction by the chemopreventive synthetic antioxidants, butylated hydroxyanisole and ethoxyquin. Biochem. Soc. Trans. 28, 33-41 (Pubitemid 30103209)
60. Rushmore, T. H. and Pickett, C. B. (1990) Transcriptional regulation of the rat glutathione S-transferase Ya subunit gene. Characterization of a xenobiotic-responsive element controlling inducible expression by phenolic antioxidants. J. Biol. Chem. 265, 14648-14653
61. + -induced oxidative stress in the blood of Parkinson's disease patients. Parkinsonism Relat. Disord. 17, 765-768
62. Venugopal, R. and Jaiswal, A. K. (1996) Nrf1 and Nrf2 positively and c-Fos and Fra1 negatively regulate the human antioxidant response element-mediated expression of NAD(P)H:quinone oxidoreductase 1 gene. Proc. Natl. Acad. Sci. U.S.A. 93, 14960-14965 (Pubitemid 26419078)
63. Siegel, D., Gustafson, D. L., Dehn, D. L., Han, J. Y., Boonchoong, P., Berliner, L. J. and Ross, D. (2004) NAD(P)H:quinone oxidoreductase 1: role as a superoxide scavenger. Mol. Pharmacol. 65, 1238-4127
64. Ernster, L. and Dallner, G. (1995) Biochemical, physiological and medical aspects of ubiquinone function. Biochim. Biophys. Acta 1271, 195-204
65. Beal, M. F., Matthews, R. T., Tieleman, A. and Shults, C. W. (1998) Coenzyme Q10 attenuates the 1-methyl-4-phenyl-1,2,3,tetrahydropyridine (MPTP) induced loss of striatal dopamine and dopaminergic axons in aged mice. Brain Res. 783, 109-114 (Pubitemid 28131427)
66. Cleren, C., Yang, L., Lorenzo, B., Calingasan, N. Y., Schomer, A., Sireci, A., Wille, E. J. and Beal, M. F. (2008) Therapeutic effects of coenzyme Q10 (CoQ10) and reduced CoQ10 in the MPTP model of Parkinsonism. J. Neurochem. 104, 1613-1621 (Pubitemid 351316765)
67. Matthews, R. T., Yang, L., Browne, S., Baik, M. and Beal, M. F. (1998) Coenzyme Q10 administration increases brain mitochondrial concentrations and exerts neuroprotective effects. Proc. Natl. Acad. Sci. U.S.A. 95, 8892-8897
68. Ferrante, R. J., Andreassen, O. A., Dedeoglu, A., Ferrante, K. L., Jenkins, B. G., Hersch, S. M. and Beal, M. F. (2002) Therapeutic effects of coenzyme Q10 and remacemide in transgenic mouse models of Huntington's disease. J. Neurosci. 22, 1592-1599 (Pubitemid 35386278)
69. Smith, R. A. and Murphy, M. P. (2010) Animal and human studies with the mitochondria-targeted antioxidant MitoQ. Ann. N.Y. Acad. Sci. 1201, 96-103
70. Sabens Liedhegner, E. A., Steller, K. M. and Mieyal, J. J. (2011) Levodopa activates apoptosis signaling kinase 1 (ASK1) and promotes apoptosis in a neuronal model: implications for the treatment of Parkinson's disease. Chem. Res. Toxicol. 24, 1644-1652
71. Sabens, E. A., Distler, A. M. and Mieyal, J. J. (2010) Levodopa deactivates enzymes that regulate thiol-disulfide homeostasis and promotes neuronal cell death: implications for therapy of Parkinson's disease. Biochemistry 49, 2715-2724
72. Lee, D. W., Kaur, D., Chinta, S. J., Rajagopalan, S. and Andersen, J. K. (2009) A disruption in iron-sulfur center biogenesis via inhibition of mitochondrial dithiol glutaredoxin 2 may contribute to mitochondrial and cellular iron dysregulation in mammalian glutathione-depleted dopaminergic cells: implications for Parkinson's disease. Antioxid. Redox Signaling 11, 2083-2094
73. Calkins, M. J., Johnson, D. A., Townsend, J. A., Vargas, M. R., Dowell, J. A., Williamson, T. P., Kraft, A. D., Lee, J. M., Li, J. and Johnson, J. A. (2009) The Nrf2/ARE pathway as a potential therapeutic target in neurodegenerative disease. Antioxid. Redox Signaling 11, 497-508
74. Perea, G., Navarrete, M. and Araque, A. (2009) Tripartite synapses: astrocytes process and control synaptic information. Trends Neurosci. 32, 421-431
75. Panatier, A., Vallee, J., Haber, M., Murai, K. K., Lacaille, J. C. and Robitaille, R. (2011) Astrocytes are endogenous regulators of basal transmission at central synapses. Cell 146, 785-798
76. Pellerin, L. and Magistretti, P. J. (2011) Sweet sixteen for ANLS. J. Cereb. Blood Flow Metab., doi:10.1038/jcbfm.2011.149
77. Pellerin, L., Bouzier-Sore, A. K., Aubert, A., Serres, S., Merle, M., Costalat, R. and Magistretti, P. J. (2007) Activity-dependent regulation of energy metabolism by astrocytes: an update. Glia 55, 1251-1262 (Pubitemid 47235366)
78. Brown, A. M. and Ransom, B. R. (2007) Astrocyte glycogen and brain energy metabolism. Glia 55, 1263-1271 (Pubitemid 47235367)
79. Suh, S. W., Bergher, J. P., Anderson, C. M., Treadway, J. L., Fosgerau, K. and Swanson, R. A. (2007) Astrocyte glycogen sustains neuronal activity during hypoglycemia: studies with the glycogen phosphorylase inhibitor CP-316,819 ([R -R*,S*]-5-chloro-N-[2-hydroxy-3-(methoxymethylamino)- 3-oxo-1-(phenylmet hyl)propyl]-1H-indole-2-carboxamide). J. Pharmacol. Exp. Ther. 321, 45-50 (Pubitemid 46456981)
80. Sofroniew, M. V. and Vinters, H. V. (2010) Astrocytes: biology and pathology. Acta Neuropathol. 119, 7-35
81. Sofroniew, M. V. (2009) Molecular dissection of reactive astrogliosis and glial scar formation. Trends Neurosci. 32, 638-647
82. Kaspar, J. W., Niture, S. K. and Jaiswal, A. K. (2009) Nrf2:INrf2 (Keap1) signaling in oxidative stress. Free Radical Biol. Med. 47, 1304-1309
83. Hayes, J. D. and McMahon, M. (2009) NRF2 and KEAP1 mutations: permanent activation of an adaptive response in cancer. Trends Biochem Sci. 34, 176-188
84. Jaiswal, A. K. (2004) Nrf2 signaling in coordinated activation of antioxidant gene expression. Free Radical Biol. Med. 36, 1199-1207
85. Escartin, C., Won, S. J., Malgorn, C., Auregan, G., Berman, A. E., Chen, P. C., Deglon, N., Johnson, J. A., Suh, S. W. and Swanson, R. A. (2011) Nuclear factor erythroid 2-related factor 2 facilitates neuronal glutathione synthesis by upregulating neuronal excitatory amino acid transporter 3 expression. J. Neurosci. 31, 7392-7401
86. Hardingham, G. E. and Lipton, S. A. (2011) Regulation of neuronal oxidative and nitrosative stress by endogenous protective pathways and disease processes. Antioxid. Redox Signaling 14, 1421-1424
87. Kraft, A. D., Johnson, D. A. and Johnson, J. A. (2004) Nuclear factor E2-related factor 2-dependent antioxidant response element activation by tert -butylhydroquinone and sulforaphane occurring preferentially in astrocytes conditions neurons against oxidative insult. J. Neurosci. 24, 1101-1112 (Pubitemid 38177017)
88. Lee, J. M., Calkins, M. J., Chan, K., Kan, Y. W. and Johnson, J. A. (2003) Identification of the NF-E2-related factor-2-dependent genes conferring protection against oxidative stress in primary cortical astrocytes using oligonucleotide microarray analysis. J. Biol. Chem. 278, 12029-12038 (Pubitemid 36800179)
89. Lee, J. M., Shih, A. Y., Murphy, T. H. and Johnson, J. A. (2003) NF-E2-related factor-2 mediates neuroprotection against mitochondrial complex I inhibitors and increased concentrations of intracellular calcium in primary cortical neurons. J. Biol. Chem. 278, 37948-37956 (Pubitemid 37175325)
90. Shih, A. Y., Johnson, D. A., Wong, G., Kraft, A. D., Jiang, L., Erb, H., Johnson, J. A. and Murphy, T. H. (2003) Coordinate regulation of glutathione biosynthesis and release by Nrf2-expressing glia potently protects neurons from oxidative stress. J. Neurosci. 23, 3394-3406 (Pubitemid 36531981)
91. Burton, N. C., Kensler, T. W. and Guilarte, T. R. (2006) In vivo modulation of the Parkinsonian phenotype by Nrf2. Neurotoxicology 27, 1094-1100 (Pubitemid 44838961)
92. Calkins, M. J., Jakel, R. J., Johnson, D. A., Chan, K., Kan, Y. W. and Johnson, J. A. (2005) Protection from mitochondrial complex II inhibition in vitro and in vivo by Nrf2-mediated transcription. Proc. Natl. Acad. Sci. U.S.A 102, 244-249 (Pubitemid 40094460)
93. Shih, A. Y., Imbeault, S., Barakauskas, V., Erb, H., Jiang, L., Li, P. and Murphy, T. H. (2005) Induction of the Nrf2-driven antioxidant response confers neuroprotection during mitochondrial stress in vivo. J Biol. Chem. 280, 22925-22936 (Pubitemid 40853201)
94. Jakel, R. J., Kern, J. T., Johnson, D. A. and Johnson, J. A. (2005) Induction of the protective antioxidant response element pathway by 6-hydroxydopamine in vivo and in vitro. Toxicol. Sci. 87, 176-186 (Pubitemid 41222670)
95. Jakel, R. J., Townsend, J. A., Kraft, A. D. and Johnson, J. A. (2007) Nrf2-mediated protection against 6-hydroxydopamine. Brain Res. 1144, 192-201 (Pubitemid 46440842)
96. Satoh, T., Okamoto, S. I., Cui, J., Watanabe, Y., Furuta, K., Suzuki, M., Tohyama, K. and Lipton, S. A. (2006) Activation of the Keap1/Nrf2 pathway for neuroprotection by electrophilic phase II inducers. Proc. Natl. Acad. Sci. U.S.A. 103, 768-773 (Pubitemid 43153100)
97. Shih, A. Y., Li, P. and Murphy, T. H. (2005) A small-molecule-inducible Nrf2-mediated antioxidant response provides effective prophylaxis against cerebral ischemia in vivo. J. Neurosci. 25, 10321-10335 (Pubitemid 41636229)
98. Chen, P. C., Vargas, M. R., Pani, A. K., Smeyne, R. J., Johnson, D. A., Kan, Y. W. and Johnson, J. A. (2009) Nrf2-mediated neuroprotection in the MPTP mouse model of Parkinson's disease: critical role for the astrocyte. Proc. Natl. Acad. Sci. U.S.A. 106, 2933-298
99. Haskew-Layton, R. E., Payappilly, J. B., Smirnova, N. A., Ma, T. C., Chan, K. K., Murphy, T. H., Guo, H., Langley, B., Sultana, R., Butterfield, D. A. et al. (2010) Controlled enzymatic production of astrocytic hydrogen peroxide protects neurons from oxidative stress via an Nrf2-independent pathway. Proc. Natl. Acad. Sci. U.S.A. 107, 17385-17390
100. Bell, K. F., Al-Mubarak, B., Fowler, J. H., Baxter, P. S., Gupta, K., Tsujita, T., Chowdhry, S., Patani, R., Chandran, S., Horsburgh, K. et al. (2011) Mild oxidative stress activates Nrf2 in astrocytes, which contributes to neuroprotective ischemic preconditioning. Proc. Natl. Acad. Sci. U.S.A. 108, E1-E2
101. Johnson, D. A., Andrews, G. K., Xu, W. and Johnson, J. A. (2002) Activation of the antioxidant response element in primary cortical neuronal cultures derived from transgenic reporter mice. J. Neurochem. 81, 1233-1241 (Pubitemid 34809257)
102. Wilde, G. J., Pringle, A. K., Wright, P. and Iannotti, F. (1997) Differential vulnerability of the CA1 and CA3 subfields of the hippocampus to superoxide and hydroxyl radicals in vitro. J. Neurochem. 69, 883-886 (Pubitemid 27327995)
103. Vornov, J. J., Park, J. and Thomas, A. G. (1998) Regional vulnerability to endogenous and exogenous oxidative stress in organotypic hippocampal culture. Exp. Neurol. 149, 109-122 (Pubitemid 28091020)
104. Semra, Y. K., Wang, M., Peat, N. J., Smith, N. C., Shotton, H. R. and Lincoln, J. (2006) Selective susceptibility of different populations of sympathetic neurons to diabetic neuropathy in vivo is reflected by increased vulnerability to oxidative stress in vitro. Neurosci. Lett. 407, 199-204 (Pubitemid 44402875)
105. McCormack, A. L., Thiruchelvam, M., Manning-Bog, A. B., Thiffault, C., Langston, J. W., Cory-Slechta, D. A. and Di Monte, D. A. (2002) Environmental risk factors and Parkinson's disease: selective degeneration of nigral dopaminergic neurons caused by the herbicide paraquat. Neurobiol. Dis. 10, 119-127 (Pubitemid 34775465)
106. Shakya, A., Cooksey, R., Cox, J. E., Wang, V., McClain, D. A. and Tantin, D. (2009) Oct1 loss of function induces a coordinate metabolic shift that opposes tumorigenicity. Nat. Cell Biol. 11, 320-327
107. Kristensen, B. W., Noraberg, J. and Zimmer, J. (2001) Comparison of excitotoxic profiles of ATPA, AMPA, KA and NMDA in organotypic hippocampal slice cultures. Brain Res. 917, 21-44 (Pubitemid 32973195)
108. Tasker, R. C., Coyle, J. T. and Vornov, J. J. (1992) The regional vulnerability to hypoglycemia-induced neurotoxicity in organotypic hippocampal culture: protection by early tetrodotoxin or delayed MK-801. J. Neurosci. 12, 4298-4308
109. Schmidt-Kastner, R. and Freund, T. F. (1991) Selective vulnerability of the hippocampus in brain ischemia. Neuroscience 40, 599-636
110. Rytter, A., Cronberg, T., Asztely, F., Nemali, S. and Wieloch, T. (2003) Mouse hippocampal organotypic tissue cultures exposed to in vitro 'ischemia' show selective and delayed CA1 damage that is aggravated by glucose. J. Cereb. Blood Flow Metab. 23, 23-33 (Pubitemid 36015091)
111. Scarpulla, R. C. (2008) Transcriptional paradigms in mammalian mitochondrial biogenesis and function. Physiol. Rev. 88, 611-638
112. St-Pierre, J., Drori, S., Uldry, M., Silvaggi, J. M., Rhee, J., Jager, S., Handschin, C., Zheng, K., Lin, J., Yang, W. et al. (2006) Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. Cell 127, 397-408 (Pubitemid 44572377)
113. Weydt, P., Pineda, V. V., Torrence, A. E., Libby, R. T., Satterfield, T. F., Lazarowski, E. R., Gilbert, M. L., Morton, G. J., Bammler, T. K., Strand, A. D. et al. (2006) Thermoregulatory and metabolic defects in Huntington's disease transgenic mice implicate PGC-1α in Huntington's disease neurodegeneration. Cell Metab. 4, 349-362 (Pubitemid 44645069)
114. Cui, L., Jeong, H., Borovecki, F., Parkhurst, C. N., Tanese, N. and Krainc, D. (2006) Transcriptional repression of PGC-1α by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration. Cell 127, 59-69 (Pubitemid 44466642)
115. McGill, J. K. and Beal, M. F. (2006) PGC-1α, a new therapeutic target in Huntington's disease? Cell 127, 465-468 (Pubitemid 44647438)
116. Qin, W., Haroutunian, V., Katsel, P., Cardozo, C. P., Ho, L., Buxbaum, J. D. and Pasinetti, G. M. (2009) PGC-1α expression decreases in the Alzheimer disease brain as a function of dementia. Arch. Neurol. 66, 352-361
117. Schapira, A. H. (2009) Neurobiology and treatment of Parkinson's disease. Trends Pharmacol. Sci. 30, 41-47
118. Mitrovic, B., Ignarro, L. J., Montestruque, S., Smoll, A. and Merrill, J. E. (1994) Nitric oxide as a potential pathological mechanism in demyelination: its differential effects on primary glial cells in vitro. Neuroscience 61, 575-585 (Pubitemid 24240305)
119. Barker, J. E., Bolaños, J. P., Land, J. M., Clark, J. B. and Heales, S. J. R. (1996) Glutathione protects astrocytes from peroxynitrite-mediated mitochondrial damage: implications for neuronal/astrocytic trafficking and neurodegeneration. Dev. Neurosci. 18, 391-396 (Pubitemid 26356691)
120. Diaz-Hernandez, J. I., Almeida, A., Delgado-Esteban, M., Fernandez, E. and Bolanos, J. P. (2005) Knockdown of glutamate-cysteine ligase by small hairpin RNA reveals that both catalytic and modulatory subunits are essential for the survival of primary neurons. J. Biol. Chem. 280, 38992-39001 (Pubitemid 41713849)
121. Hirrlinger, J., Schulz, J. B. and Dringen, R. (2002) Glutathione release from cultured brain cells: multidrug resistance protein 1 mediates the release of GSH from rat astroglial cells. J. Neurosci. Res. 69, 318-326 (Pubitemid 34809481)
122. Dringen, R., Pfeiffer, B. and Hamprecht, B. (1999) Synthesis of the antioxidant glutathione in neurons: supply by astrocytes of CysGly as precursor for neuronal glutathione. J. Neurosci. 19, 562-569 (Pubitemid 29036007)
123. Vargas, M. R., Johnson, D. A., Sirkis, D. W., Messing, A. and Johnson, J. A. (2008) Nrf2 activation in astrocytes protects against neurodegeneration in mouse models of familial amyotrophic lateral sclerosis. J. Neurosci. 28, 13574-13581
124. Chinta, S. J., Kumar, M. J., Hsu, M., Rajagopalan, S., Kaur, D., Rane, A., Nicholls, D. G., Choi, J. and Andersen, J. K. (2007) Inducible alterations of glutathione levels in adult dopaminergic midbrain neurons result in nigrostriatal degeneration. J. Neurosci. 27, 13997-14006 (Pubitemid 351377875)
125. Garrido, M., Tereshchenko, Y., Zhevtsova, Z., Taschenberger, G., Bahr, M. and Kugler, S. (2011) Glutathione depletion and overproduction both initiate degeneration of nigral dopaminergic neurons. Acta Neuropathol. 121, 475-485
126. Garcia-Nogales, P., Almeida, A. and Bolanos, J. P. (2003) Peroxynitrite protects neurons against nitric oxide-mediated apoptosis. A key role for glucose-6-phosphate dehydrogenase activity in neuroprotection. J. Biol. Chem. 278, 864-874 (Pubitemid 36790760)
127. Bolaños, J. P. and Almeida, A. (2010) The pentose-phosphate pathway in neuronal survival against nitrosative stress. IUBMB Life 62, 14-18
128. Vogel, R., Wiesinger, H., Hamprecht, B. and Dringen, R. (1999) The regeneration of reduced glutathione in rat forebrain mitochondria identifies metabolic pathways providing the NADPH required. Neurosci. Lett. 275, 97-100 (Pubitemid 29502545)
129. Hirrlinger, J. and Dringen, R. (2010) The cytosolic redox state of astrocytes: Maintenance, regulation and functional implications for metabolite trafficking. Brain Res. Rev. 63, 177-188
130. Wamelink, M. M., Struys, E. A. and Jakobs, C. (2008) The biochemistry, metabolism and inherited defects of the pentose phosphate pathway: a review. J. Inherit. Metab. Dis. 31, 703-717
131. Herrero-Mendez, A., Almeida, A., Fernandez, E., Maestre, C., Moncada, S. and Bolaños, J. P. (2009) The bioenergetic and antioxidant status of neurons is controlled by continuous degradation of a key glycolytic enzyme by APC/C-Cdh1. Nat. Cell Biol. 11, 747-752
132. Diaz-Hernandez, J. I., Moncada, S., Bolaños, J. P. and Almeida, A. (2007) Poly(ADP-ribose) polymerase-1 protects neurons against apoptosis induced by oxidative stress. Cell Death Differ. 14, 1211-1221 (Pubitemid 46785110)
133. Eggleston, L. V. and Krebs, H. A. (1974) Regulation of the pentose phosphate cycle. Biochem. J. 138, 425-435
134. Ben-Yoseph, O., Boxer, P. A. and Ross, B. D. (1996) Assessment of the role of the glutathione and pentose phosphate pathways in the protection of primary cerebrocortical cultures from oxidative stress. J. Neurochem. 66, 2329-2337 (Pubitemid 26159067)
135. Delgado-Esteban, M., Almeida, A. and Bolaños, J. P. (2000) D-Glucose prevents glutathione oxidation and mitochondrial damage after glutamate receptor stimulation in rat cortical primary neurons. J. Neurochem. 75, 1618-1624
136. Silverman, D. H., Small, G. W., Chang, C. Y., Lu, C. S., Kung De Aburto, M. A., Chen, W., Czernin, J., Rapoport, S. I., Pietrini, P., Alexander, G. E. et al. (2001) Positron emission tomography in evaluation of dementia: regional brain metabolism and long-term outcome. JAMA, J. Am. Med. Assoc. 286, 2120-2127 (Pubitemid 34041597)
137. Soucek, T., Cumming, R., Dargusch, R., Maher, P. and Schubert, D. (2003) The regulation of glucose metabolism by HIF-1 mediates a neuroprotective response to amyloid β peptide. Neuron 39, 43-56 (Pubitemid 36830947)
138. Russell, R. L., Siedlak, S. L., Raina, A. K., Bautista, J. M., Smith, M. A. and Perry, G. (1999) Increased neuronal glucose-6-phosphate dehydrogenase and sulfhydryl levels indicate reductive compensation to oxidative stress in Alzheimer disease. Arch. Biochem. Biophys. 370, 236-239 (Pubitemid 29491430)
139. Palmer, A. M. (1999) The activity of the pentose phosphate pathway is increased in response to oxidative stress in Alzheimer's disease. J. Neural Transm. 106, 317-328
140. Ferreira, I. L., Cunha-Oliveira, T., Nascimento, M. V., Ribeiro, M., Proenca, M. T., Januario, C., Oliveira, C. R. and Rego, A. C. (2011) Bioenergetic dysfunction in Huntington's disease human cybrids. Exp. Neurol. 231, 127-134
141. Hardie, D. G., Carling, D. and Sim, A. T. R. (1989) The AMP-activated protein kinase: a multisubstrate regulator of lipid metabolism. Trends Biochem. Sci. 14, 20-23 (Pubitemid 19031701)
142. Almeida, A., Moncada, S. and Bolaños, J. P. (2004) Nitric oxide switches on glycolysis through the AMP protein kinase and 6-phosphofructo-2- kinase pathway. Nat. Cell Biol. 6, 45-51 (Pubitemid 38425729)
143. Ventura, F., JL, R., Ambrosio, S., Gil, J. and Bartrons, R. (1991) 6-Phosphofructo-2- kinase/fructose-2,6-bisphosphatase in rat brain. Biochem. J. 276, 455-460
144. 2+ homeostasis. J. Neurochem. 66, 403-411
145. Kauppinen, R. A. and Nicholls, D. G. (1986) Failure to maintain glycolysis in anoxic nerve terminals. J. Neurochem. 47, 1864-1869 (Pubitemid 17191503)
146. Choi, S. W., Gerencser, A. A. and Nicholls, D. G. (2009) Bioenergetic analysis of isolated cerebrocortical nerve terminals on a microgram scale: spare respiratory capacity and stochastic mitochondrial failure. J. Neurochem. 109, 1179-1191
147. Xu, Y., Ola, M. S., Berkich, D. A., Gardner, T. W., Barber, A. J., Palmieri, F., Hutson, S. M. and LaNoue, K. F. (2007) Energy sources for glutamate neurotransmission in the retina: absence of the aspartate/glutamate carrier produces reliance on glycolysis in glia. J. Neurochem. 101, 120-131 (Pubitemid 46426472)
148. Bringmann, A., Pannicke, T., Biedermann, B., Francke, M., Iandiev, I., Grosche, J., Wiedemann, P., Albrecht, J. and Reichenbach, A. (2009) Role of retinal glial cells in neurotransmitter uptake and metabolism. Neurochem. Int. 54, 143-160
149. i and mitochondrial membrane potential in glutamate toxicity. J. Neurochem. 109, 644-655
150. Kasischke, K. A., Vishwasrao, H. D., Fisher, P. J., Zipfel, W. R. and Webb, W. W. (2004) Neural activity triggers neuronal oxidative metabolism followed by astrocytic glycolysis. Science 305, 99-103 (Pubitemid 38869381)
151. Porras, O. H., Loaiza, A. and Barros, L. F. (2004) Glutamate mediates acute glucose transport inhibition in hippocampal neurons. J. Neurosci. 24, 9669-9673 (Pubitemid 39441521)
152. Almeida, A., Bolanos, J. P. and Moreno, S. (2005) Cdh1/Hct1-APC is essential for the survival of postmitotic neurons. J. Neurosci. 25, 8115-8121 (Pubitemid 41292106)
153. Pellerin, L. and Magistretti, P. J. (1994) Glutamate uptake into astrocytes stimulates aerobic glycolysis: a mechanism coupling neuronal activity to glucose utilization. Proc. Natl. Acad. Sci. U.S.A. 91, 10625-10629 (Pubitemid 24329051)
154. + and a delayed and persistent effect of glutamate. J. Neurosci. 31, 4709-4713
155. Pellerin, L., Pellegri, G., Bittar, P. G., Charnay, Y., Bouras, C., Martin, J. L., Stella, N. and Magistretti, P. J. (1998) Evidence supporting the existence of an activity-dependent astrocyte-neuron lactate shuttle. Dev. Neurosci. 20, 291-299 (Pubitemid 28495523)
156. Schurr, A. (2006) Lactate: the ultimate cerebral oxidative energy substrate? J. Cereb. Blood Flow Metab. 26, 142-152
157. Suzuki, A., Stern, S. A., Bozdagi, O., Huntley, G. W., Walker, R. H., Magistretti, P. J. and Alberini, C. M. (2011) Astrocyte - neuron lactate transport is required for long-term memory formation. Cell 144, 810-823
158. Magistretti, P. J. (2006) Neuron - glia metabolic coupling and plasticity. J. Exp. Biol. 209, 2304-2311
159. Hertz, L., Peng, L. and Dienel, G. A. (2007) Energy metabolism in astrocytes: high rate of oxidative metabolism and spatiotemporal dependence on glycolysis/glycogenolysis. J. Cereb. Blood Flow Metab. 27, 219-249 (Pubitemid 46148451)
160. Figley, C. R. (2011) Lactate transport and metabolism in the human brain: implications for the astrocyte - neuron lactate shuttle hypothesis. J. Neurosci. 31, 4768-4770